Abstract:Positron emission tomography (PET) is a nuclear medicine imaging method in which radioisotopes are employed to label biochemical substrates for use as tracers to follow function and physiology inside living bodies. Its role as an important medical diagnostic imaging tool has been broadly accepted. More recently, its use as a basic biological imaging tool for study of fundamental biomedical processes in laboratories is being developed rapidly. PET technology involves production of radioisotopes using compact cyclotron, capture ofphotons by scintillation detectors or their comparable devices, processes of converting photons into electrical signals and in tum image data, reconstruction of images from projections, physiological modeling, image analysis, and applications in routine medical practice and in laboratory sciences. Recent advances in computing and detector technologies have made PET imaging quantitatively more reliable with high image quality. PET has become an important molecular imaging probe for assessing functional and physiological information at the cellular and molecular level. Examples of its use as a molecular imaging technology include clinical diagnosis and monitoring of responses to treatments, brain mapping, genetic studies, and drug discovery and assessment.

Research progress of 18F labeled small molecule positron emission tomography (PET) imaging agents

Methodological Progress of 18 F-labeled Aromatic PET Radiotracers

Recent advances in photochemistry for positron emission tomography imaging

Non-[18F]FDG PET-Radiopharmaceuticals in Oncology

Radiosynthesis of fluorine-1 8 labeled PET imaging agents

18F Labeled benzimidazole derivatives as potential radiotracer for positron emission tomography (PET) tumor imaging

Prospect of Study and Application on PET Receptor Imaging

Microfluidics for synthesis of peptide-based PET tracers.

PET Probes Beyond (18)F-FDG.

Fluorine-18: Radiochemistry and Target-Specific PET Molecular Probes Design.

Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography

Current Researches and Progress on Preparation of 18F Labeled Positron Radiopharmacueticals

Functional and Molecular Imaging Using Positron Emission Tomography

Noninvasive imaging of FAP expression using positron emission tomography: A comparative evaluation of a [18F]-labeled glycopeptide-containing FAPI with [18F]FAPI-42

New Methods and Techniques for F-18-Labeled Radiopharmaceuticals

Synthetic 18 F labeled biomolecules that are selective and promising for PET imaging: Major advances and applications

Clinical Applications of Small-molecule PET Radiotracers: Current Progress and Future Outlook

[Recent progress of positron radionuclide labeled small molecule inhibitors of prostate specific membrane antigen for PET/CT imaging of prostate cancer].

Recent Progress in the Study of Fluorine-18 Labelled Peptide Radiopharmaceticals

The research progress of radionuclide molecular imaging for breast cancer

R & D Trends of New Drugs for PET/CT Brain Imaging and R & D of New Drugs for Brain Imaging Based on the PET/CT System